Venu Nair, MD
Nephrology · Kansas City, KSNPI 1184783193
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Medtronic at 49.8% of the total. Reporting peaked in 2022 at $188 and has fallen 59.3% since, to $77 in 2025. That places this record below the midpoint for nephrology clinicians in KS, where the typical reported total is $931.
Across 21 payments — averaging $20.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$217
- Mozarc Medical US LLC$82
- Bard Peripheral Vascular, Inc.$44
- Venturemed Group, Inc.$34
- Amgen$30
- Daiichi Sankyo Inc.$17
- plus $11 from 1 others
What the payments were for
- Food & beverage$436100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 10 | $217 |
| Mozarc Medical US LLC | 4 | $82 |
| Bard Peripheral Vascular, Inc. | 2 | $44 |
| Venturemed Group, Inc. | 1 | $34 |
| Amgen | 2 | $30 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Cardinal Health 200 LLC | 1 | $11 |
How this compares
$436 in reported general payments places this provider in the 35th percentile of 55 nephrology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sevelamer Carbonate | 52 | $7,065 |
| Calcium Acetate | 41 | $2,627 |
| Metolazone | 47 | $1,406 |
| Potassium Chloride | 54 | $1,091 |
| ClinisolParenteral Amino Acid 15% No.5 | 15 | $1,010 |
| Allopurinol | 11 | $761 |
| Gentamicin Sulfate | 21 | $751 |
| Doxazosin Mesylate | 33 | $621 |
| Amlodipine Besylate | 89 | $470 |
| Midodrine Hcl | 14 | $461 |
| Hydralazine Hcl | 33 | $397 |
| Losartan Potassium | 52 | $360 |
| Furosemide | 52 | $341 |
| Calcitriol | 16 | $275 |
| Carvedilol | 43 | $235 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Kansas City
- Aditi GuptaKansas City$16K
- Alan YuKansas City$16K
- Ahmad TuffahaKansas City$15K
- Diane CibrikKansas City$12K
- Duncan JohnstoneKansas City$4K
- Amna IlaheKansas City$2K
- Sri YarlagaddaKansas City$1K
- Reem MustafaKansas City$1K
- Itunu OwoyemiKansas City$931
- Andrew StingoKansas City$637
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.